Georgia Bio’s Post

If you are at #bioeuropespring be sure to drop by One Nucleus booth 102B to discuss how CPI can help accelerate your biological therapeutics to market. #BioEuropeSpring #LetsInnovateTogether #CPI #Innovation #Pharma #Upstream #Downstream #Analytical #Formulation #ProcessDevelopment #Microbial #Mammalian #ViralVectors #mRNA #Vaccines #Microbiome #Phage

RESISTANCE IS NOT AN OPTION

Following recent news from Charles River Laboratories, regarding their continued investment into their Alternative Methods Advancement Project (AMAP), to reduce reliance on animal testing - we are thrilled to share a collaborative #genotoxicity publication between CRL, CN Bio and TwinStrand Biosciences. The publication demonstrates that Liver-on-a-chip is a promising tool for genotoxicity assessment. Click the link to learn more & congrats to all involved! #animalalternatives #organonchip #microphysiologicalsystem

Excited to announce that I will be attending Bioeurope Spring, one of the most prominent biotech partnering conferences! Looking forward to connecting with industry leaders, exploring innovative collaborations, and staying up-to-date with the latest trends in the life sciences sector. If you'll be there too, I would love to meet up and discuss potential opportunities. See you at #BioEuropeSpring! #MilliporeCTDMO #Drugconjugate #smallmolecule #HPAPI #linkerpayload"

Beyond excited to share the news that #CreyonBio is presenting clinical data for AI-assisted antisense oligonucleotide drug discovery at the ASGCT meeting! It's been an incredible journey, and I'm extremely fortunate and proud to be a part of such an outstanding team. Thank you to everyone who has supported us along the way! 🌟 #ASGCT #BiotechInnovation #DrugDiscovery #CreyonBio Snippet from the Press Release:- ".....Within one year of project initiation in partnership with The TNPO2 Foundation, Creyon developed a novel allele-selective Locked Nucleic Acid (LNA) treatment candidate for an ultra-rare and severe neurological disease caused by a single nucleotide variant in the Transportin-2 (TNPO2) receptor, and an investigator-initiated clinical trial received approval to dose a patient........This treatment has been well-tolerated with no increase in inflammatory markers in the cerebrospinal fluid (CSF) or adverse changes on brain MRI scans. Notably, the patient experienced reduced seizure frequency after the second dose and regained developmental milestones including rolling, sustained attention and gaining novel skills such as tripod sitting and responsive babbling after the third dose......" https://lnkd.in/g3TA7FH9

Missed our webinar on macrocyclic lead optimisation last week? Catch up on-demand on our website whenever you like. Watch now at https://lnkd.in/e5Q9EtMv In the webinar, our experts Ajay Jain and Ann Cleves Jain take a practical approach to macrocycle optimisation, discussing two recent case studies published in collaboration with Bristol Myers Squibb and Corteva Agriscience, and discuss how to effectively model structurally complex macrocycles. #LeadOptimisation #Macrocycles #Research #Collaboration

The Life Science Barometer 2024 is here! 🥁 After months of conducting our most comprehensive qualitative study with 200 participating companies SwedenBIO is proud to finally present The Life Science Barometer 2024 - a snapshot of the Swedish Life Science industry. ➡ Who should read the report? National policy makers, life science executives and investors. ➡ What is it?  Every year, SwedenBIO conducts a qualitative study with Swedish life science executives. The resulting “Barometer” is our most important publication, outlining the state of the industry. ➡ Why is it important? With so many executives providing input, this report offers a unique alternative to standardized statistics. ➡ Click here to read the report: https://lnkd.in/dmzRVvhX   SwedenBIO extends our heartfelt thanks to our partners who helped in conducting the study: Medicon Village Innovation, Sahlgrenska Science Park, Stockholm Science City Foundation, STUNS Life science and Citeline. Dajana I. Sarah Lidé Kajsa Liljegren Jamie Smith Maja Neiman #LifeScience #LifeScienceBarometer #Pharma #IndustryReport #PolicyMakers

AgriNovus Indiana put together a great group of speakers yesterday! I found Jim's talk on what we should expect to see from ag biotech in the future to be impactful, and that we needed to "dial up our expectations for change". RTI and AgriNovus put together a report on how the state of Indiana has performed in the Ag Bioscience field, and where we should expect to see things in the future. https://lnkd.in/gMaTSh5d

Exciting news! Today, the SwedenBIO Life Science Barometer 2024 has been launched! The Barometer provides a snapshot of the Swedish life science industry, capturing optimism, concerns, and trends from 200 industry executives surveyed in October 2023. Key figures from the report: 🔸 Medtech is the largest segment with 61% of a total of 4,000 companies in the industry. 🔸 Research and development is the main activity among small and medium-sized companies. 🔸 A majority of the companies are privately owned. 🔸 Financing is the biggest concern for the companies. 🌐 Click here to explore the report: https://lnkd.in/drcrJQfq The Life Science Barometer 2024, produced by SwedenBIO in collaboration with Medicon Village, Sahlgrenska Science Park, Stockholm Science City Citeline and STUNS Life science, promises unique perspectives absent in previous statistics. Our collaboration contributes to a nationwide effort in measuring the life science industry. Additionally its also complementing #InsightMachine, a database developed by STUNS, tailored to provide valuable insights into life science companies in Sweden. 🔬Sign up for Insight Machine and unlock valuable INSIGHTS! https://lnkd.in/dZAtmy3K Stay tuned for the upcoming regional (Uppsala) report, sparking more discussions and analyses. #LifeScience #Collaboration

Swing by and chat with myself and Hannah Roddy. We would love to introduce you to Inventia Life Science and the #RASTRUM #biotech #cells #cellmodeling #celltherapy #drugdevelopment #drugdiscovery #invinvo